Simon Burton
Analyst · Solo Capital Management. Please go ahead
Good morning and thank you for joining our call today. I am pleased to report that we made solid progress in several fronts during the quarter. Our underwriting results, excluding the impact of COVID-19, which I'll discuss shortly, generated a combined ratio of 95.7%. This result continues the trend of improved underlying performance and reflects the repositioning of our underwriting business over the past three years. During this time, we have expanded the lines of business we write and increased our participation in excess of loss contracts when the economics support it, thereby replacing some of our lower-performing quota share contracts with higher-margin business. It is notable that over the past three years, we have decided to not renew approximately two thirds of the premium that was enforced as of July 2017, so we have been acutely selective of the business that we keep. Looking forward, the improvement in market conditions that started last year is now accelerating. Over the past few months, we have seen risk placements in specialty classes with significantly improved terms. We have also seen that attempts to place risks with only modest pricing improvements are often met with shortfalls in capacity, a clear sign of a healthy market. Given the recent timing of these more significant pricing movements, the impact on our income statement this quarter is negligible, although we are optimistic that we will see the benefit over the next year. Our exposure to the pandemic continues to be manageable and small in comparison to the industry as a whole, a result that reflects several factors. We have minimal exposure to some of the highly exposed lines of business, where coverage is uncontested, such as event cancellation, travel insurance, trade credits, directors' and officers' liability and long-term life. While the mortgage market has seen an increase in delinquencies, the financial impact on our portfolio has been offset by reductions in profit commissions we paid to our cedents. Additionally, over the last two years, we cut back on the amount of mortgage business we write, which reduces our exposure to the newer and therefore, riskier underlying mortgage contracts. And as we anticipated, our auto business has shown a reduction in claim frequency through the lockdown period in the US. Our second quarter COVID-19 net loss estimate of $6 million contributed 5.5 points to our total combined ratio of 101.2%. This loss estimate relates primarily to our Lloyd's multi-class contracts and certain property catastrophe contracts with identifiable business interruption exposure. Regarding our key financial metric, we grew book value per share by 1.5% as we took advantage of the opportunity to repurchase shares at a significant discount to book. On the investment side, David will discuss Solasglas and the broader environment in a moment, but it's notable that contributing to our overall investment result this quarter is a gain of $3.3 million in the valuation of certain strategic investments made by our innovations unit. The pandemic has exposed both winners and losers among our innovation partners. And overall, I'm pleased with our progress and excited about the division's potential. Finally, AM Best recently concluded our annual review with the decision to affirm our A minus rating. Ratings pressure has been a common theme in the industry in recent months, with several notable ratings downgrades. We are pleased with AM Best's decision, and I look forward to executing our plans to build shareholder value as we move into much improved market conditions. Now I'd like to turn the call over to David.